ArticleScientific reports2025

Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors.

J Abraham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.